The Human Ribonucleotide Reductase Subunit hRRM2 Complements p53R2 in Response to UV-Induced DNA Repair in Cells with Mutant p53

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6583-6594

  Zhou, Bingsen ^a   Liu, Xiyong ^a   Mo, Xueli ^a   Xue, Lijun ^a   Darwish, Dana ^a   Qiu, Weihua ^a   Shih, Jennifer ^a   Hwu, Edward B ^a   Luh, Frank ^a   Yen, Yun ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOSIDE DIPHOSPHATE; PROTEIN P53; RIBONUCLEOSIDE DIPHOSPHATE; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE HRRM1; RIBONUCLEOTIDE REDUCTASE HRRM2; RIBONUCLEOTIDE REDUCTASE P53R2; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DNA REPAIR; DNA SYNTHESIS; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; ULTRAVIOLET RADIATION;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYUREA; KB CELLS; MALE; MUTATION; PROSTATIC NEOPLASMS; PROTEIN BINDING; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; RIBONUCLEOTIDE REDUCTASES; RNA, ANTISENSE; RNA, MESSENGER; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 0142250911     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Jordan, A., and Reichard, P. Ribonucleotide reeducates. Annu. Rev. Biochem., 67: 71-98, 1998.
2. Thelander, L., and Berg, P. Isolalion and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase. Mol. Cell. Biol., 6: 3433-3442, 1986.
3. Chang, C. H., and Cheng, Y. C. Substrate specificity of human ribonucleotide reductase from Molt-4F cells. Cancer Res., 39: 5081-5086, 1979.
4. Thelander, M., Graslund, A., and Thelander, L. Subunit M2 of mammalian ribonucleotide reductase. J. Biol. Chem., 260: 2737-2741, 1985.
5. Yen, Y., Grill, S. P., Dutschman, G. E., Chang, C. N., Zhou, B. S., and Cheng, Y. C. Characterization of hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine. Cancer Res., 54: 3686-3691, 1994.
6. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura, Y. A ribonucleotide reductase gene involved ill in p53-dependent cell-cycle checkpoint for DNA damage. Nature (Lond.), 404: 42-49, 2000.
7. Guitlet, O., Håkansson, P., Voevodskaya, N., Gräslund, A., Arakawa, H., Nakamura, Y., and Thelander, L. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J. Biol. Chem., 276: 40647-40651, 2001.
8. Lozano, G., and Elledge, S. J. p53 sends nucleotides to repair DNA. Nature (Lond.), 404: 24-25, 2000.
9. Morgan, S. E., and Kastan, M. B. p53 and ATM: cell cycle, cell cycle death, and cancer. Adv. Cancer Res., 71: 1-25, 1997.
10. Linke, S. P., Clarkin, K. C., and Wahl, G. M. p53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation. Cancer Res., 57: 1171-1179, 1997.
11. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
12. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.
13. Bennett, M., MacDonald, K., Chan, S. W., Luzio, J. P., Simari, R., and Weissberg, P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science (Wash. DC), 282: 290-293, 1998.
14. Xue, L., Zhou, B., Liu, X., Qiu, W., Jin, Z., and Yen, Y. Wild type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res., 63: 980-986, 2003.
15. Friedberg, E. C., Walker, G. C., and Siede, W. (eds.). DNA Repair and Mutagenesis. Washington, DC: American Society for Microbiology Press, 1995.
16. Wright, J. A., Chan, A. K., Choy, B. K., Hurta, R. A., and McClarty, G. A. Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis. Biochem. Cell Biol., 68: 1364-1371, 1990.
17. Hurta, R. A., and Wright, J. A. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent. J. Biol. Chem., 267: 7066-7071, 1992.
18. Smith, M. L., and Sco, Y. R. p53 regulation of DNA excision repair pathways. Mutagenesis, 17: 149-156, 2002.
19. Eriksson, S., Graslund, A., Skog, S., Thelander, L., and Tribukait, B. Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J. Biol. Chem., 259: 11695-11700, 1984.
20. Albert, D. A., Nodzenski, E., Yim, G., and Kowalski, J. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells. J. Cell. Physiol., 143: 251-256, 1990.
21. Nakano, K., Bálint, E., Asheroft, M., and Vousden, K. H. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene, 19: 4283-4289, 2000.
22. Engstrom, Y., Eriksson, S., Jildevik, I., Skog, S., Thelander, L., and Tribukait, B. Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J. Biol. Chem., 260: 9114-9116, 1985.
23. Mann, G. J., Musgrove, E. A., Fox, R. M., and Thelander, L. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Cancer Res., 48: 5151-5156, 1988.
24. Björklund, S., Hjortsberg, K., Johansson, E., and Thelander, L. Structure and promoter characterization of the gene encoding the large subunit (R1 protein) of mouse ribonucleotide reductase. Proc. Natl. Acad. Sci. USA, 90: 11322-11326, 1993.
25. Sun, L., and Fuchs, J. A. Escherichia coli ribonucleotide reductase expression is cell cycle regulated. Mol. Biol. Cell, 3: 1094-1105, 1992.
26. Elledge, S. J., and Davis, R. W. DNA damage induction of ribonucleotide reductase. Mol. Cell. Biol., 9: 4932-4940, 1989.
27. Kuo, M. L., and Kinsella, T. J. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. Cancer Res., 58: 2245-2252, 1998.
28. Chen, S. Y., Zhou, B. S., He, F. Q., and Yen, Y. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA. Antisense Nucleic Acid Drug Dev., 10: 111-116, 2000.
29. Smith, M. L., Chen, I. T., Zhan, Q., O'Connor, P. M., and Fornace, A. J., Jr. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene, 10: 1053-1059, 1995.
30. Ford, J. M., and Hanawalt, P. C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV-resistance. Proc. Natl. Acad. Sci. USA, 92: 8876-8880, 1995.
31. Ford, J. M., and Hanawalt, P. C. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem., 272: 28073-28080, 1997.
32. Ford, J. M., Baron, E. L., and Hanawalt, P. C. Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation. Cancer Res., 58: 599-603, 1998.
33. Smith, M. L., and Fornace, Jr., A. J. P53-mediated protective responses to UV-irradiation. Proc. Natl. Acad. Sci. USA, 94: 12255-12257, 1997.
34. Leveillard. T., Andera, L., Bissonette, N., Schaeffer, L., Bracco, L., Egly, J. M., and Waslyk, B. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J., 15: 1615-1624, 1996.
35. Wang, X. W., Yeh, H., Schaeffner, L., Roy, R., Moncollin, V., Egly, J. M., Wang, Z., Friedberg, E. C., Evans, M. K., Taffe, B. G., et al. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet., 10: 188-195, 1995.
36. Hwang, B. J., Toering, S., Francke, U., and Chu, G. p48 activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity. Mol. Cell. Biol., 18: 4391-4399, 1998.
37. Hwang, B. J., Ford, J. M., Hanawalt, P. C., and Chu, G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA, 96: 424-428, 1999.
38. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
39. Therrian, J. P., Drouin, R., Baril, C., and Drobetsky, E. A. Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair. Proc. Natl. Acad. Sci. USA, 96: 15038-15043, 1999.
40. Takakawa, M., and Saito, H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/
41. Kearsey, J., Coates, P. J., Prescott, A. R., Warbrick, E., and Hall, P. A. GADD45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene, 11: 1675-1683, 1995.
42. Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., and Kelly, K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89: 1175-1184, 1997.
43. Gu, W., Shi, X. L., and Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature (Lond.), 387: 819-823, 1997.
44. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livinston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature (Lond.), 387: 823-827, 1997.
45. Engstrom, Y., Rozell, B., Hansson, H. A., Stemme, S., and Thelander, L. Localization of ribonucleotide reductase in mammalian cells. EMBO J., 3: 863-867, 1984.
46. Engstrom, Y., and Rozell, B. Immunocytochemical evidence for the cytoplasmic localization and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase. EMBO J., 7: 1615-1620, 1988.
47. Reddy, G. P., and Fager, R. S. Replitase: a complex integrating dNTP synthesis and DNA replication. Crit. Rev. Eukaryotic Gene Expression, 3: 255-277, 1993.
48. Yamaguchi, T., Matsuda, K., Sagiya, Y., Iwadate, M., Fujino, M. A., Nakamura, Y., and Arakawa, H. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint. Cancer Res., 61: 8256-8262, 2001.
49. Gao, S., Drouin, R., and Holmquist, G., P. DNA repair rates mapped along the human PGK1 gene at nucleotide resolution. Science (Wash. DC), 263: 1438-1440, 1994.
50. Ye, N., Bianchi, M. S., Bianchi, N. O., and Holmquist, G. P. Adaptive enhancement and kinetics of nucleoticle excision repair in humans. Mutat. Res., 435: 43-61, 1999.
51. Tornaletti, S., and Pfeifer, G. P. Slow repair of pyrimidine dimmers at p53 mutation hotspots in skin cancer. Science (Wash. DC), 263: 1436-1438, 1994.
52. Freedman, D. A., Wu, L., and Levine, A. J. Functions of the MDM2 oncoprotein. Cell Mol. Life Sci., 55: 96-107, 1999.
53. Lakin, N. D., and Jackson, S. P. Regulation of p53 in response to DNA damage. Oncogene, 18: 7644-7655, 1999.